홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

Hydrochloric Acid → n-({3-[(3-{[(5-Chloro-2-thienyl)sulfonyl]amino}-4-hydroxy-1h-indazol-1-yl)methyl]phenyl}methyl)-3-morpholinecarboxamide formate salt

HRID 1892958
인쇄

반응식

HRID 1892958 반응식
[N:1]1([O:10][C:11](N(C)C)=[N+](C)C)[C:5]2[N:6]=[CH:7][CH:8]=[CH:9][C:4]=2N=[N:2]1.F[P-](F)(F)(F)(F)F.C([O:29]C([N:32]1[CH2:37][CH2:36][O:35][CH2:34][CH:33]1[C:38]([OH:40])=O)=O)(C)(C)C.[CH:41](N(CC)C(C)C)([CH3:43])[CH3:42].C(O)=O.NCC1C=C(CN2[C:70]3[C:65](=[C:66]([OH:71])[CH:67]=[CH:68][CH:69]=3)[C:64]([NH:72][S:73]([C:76]3[S:77][C:78]([Cl:81])=[CH:79][CH:80]=3)(=[O:75])=[O:74])=N2)C=CC=1.ClC1SC(S(NC2C3C(=CC=CC=3O)N(CC3C=C(CNC(C4COCCN4C(OC(C)(C)C)=O)=O)C=CC=3)N=2)(=O)=O)=CC=1.Cl.O1CCOCC1>CN(C=O)C.ClCCl.CO>[CH:11]([OH:10])=[O:29].[Cl:81][C:78]1[S:77][C:76]([S:73]([NH:72][C:64]2[C:65]3[C:70](=[CH:69][CH:68]=[CH:67][C:66]=3[OH:71])[N:1]([CH2:5][C:4]3[CH:9]=[C:8]([CH2:7][NH:6][C:38]([CH:33]4[CH2:34][O:35][CH2:36][CH2:37][NH:32]4)=[O:40])[CH:42]=[CH:41][CH:43]=3)[N:2]=2)(=[O:75])=[O:74])=[CH:80][CH:79]=1
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

11

반응물 7

HCID 313Hydrochloric Acid3회HCID 312751,4-DioxaneHCID 81531DiisopropylethylamineHCID 27601334-(tert-Butoxycarbonyl)morpholine-3-carboxylic acidHCID 9886157Methanaminium, N-((dimethylamino)(3H-1,2,3-triazolo(4,5-b)pyridin-3-yloxy)methylene)-N-methyl-, hexafluorophosphate(1-) (1:1)
HCID 136346357
n-(1-{[3-(Aminomethyl)phenyl]methyl}-4-hydroxy-1h-indazol-3-yl)-5-chloro-2-thiophenesulfonamide formate salt
HCID 1363463601,1-dimethylethyl 3-{[({3-[(3-{[(5-chloro-2-thienyl)sulfonyl]amino}-4-hydroxy-1H-indazol-1-yl)methyl]phenyl}methyl)amino]carbonyl}-4-morpholinecarboxylate

생성물 1

HCID 136346359n-({3-[(3-{[(5-Chloro-2-thienyl)sulfonyl]amino}-4-hydroxy-1h-indazol-1-yl)methyl]phenyl}methyl)-3-morpholinecarboxamide formate salt수율 43%

시약·촉매·용매 3

HCID 887Methanol용매2회HCID 6228Dimethylformamide용매2회HCID 6344Dichloromethane용매

실험 절차

To a solution of O-(7-azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium-hexafluorophosphate (43.8 mg, 0.071 mmol) in anhydrous DMF (1 mL) was added at room temperature morpholine-3,4-dicarboxylic acid 4-tert-butyl ester (Fluorochem) (14.95 mg, 0.065 mmol) followed by N,N-diisopropylethylamine (0.034 ml, 0.19 mmol) and finally a solution of N-(1-{[3-(aminomethyl)phenyl]methyl}-4-hydroxy-1H-indazol-3-yl)-5-chloro-2-thiophenesulfonamide formate salt (for a preparation see Intermediate 15) (32 mg, 0.065 mmol) in anhydrous DMF (1 mL) and the reaction mixture was stirred at room temperature for 30 min. The reaction mixture was partitioned between saturated aqueous sodium hydrogen carbonate solution and ethyl acetate. The organic layer was separated, washed with brine-water (1:1), passed through a hydrophobic frit, and evaporated in-vacuo to yield a colourless oil. LCMS (System B) RT=2.91 min, ES+ve m/z 662/664 (M+H)+ for 1,1-dimethylethyl 3-{[({3-[(3-{[(5-chloro-2-thienyl)sulfonyl]amino}-4-hydroxy-1H-indazol-1-yl)methyl]phenyl}methyl)amino]carbonyl}-4-morpholinecarboxylate. This was suspended in anhydrous dichloromethane (2 mL) and treated with a solution of hydrogen chloride in 1,4-dioxane (4M, 0.162 mL, 0.646 mmol). The reaction mixture was still a suspension, therefore methanol was added dropwise until the reaction was in solution. The mixture was stirred at room temperature for 1 hour, and a further portion of hydrogen chloride solution (4M, 0.162 mL) was added to the reaction mixture and stirred for 90 min. Yet another portion of hydrogen chloride solution (4M, 0.162 mL) was added to the reaction mixture and stirred for 90 min. The reaction mixture was evaporated in-vacuo to yield a colourless oil. The residual oil was dissolved in MeOH:DMSO (1 mL) and purified by MDAP Sunfire C18 column, eluting with solvents A/B (A: 0.1% v/v solution of formic acid in water, B: 0.1% v/v solution of formic acid in acetonitrile) (25 min run). Appropriate fractions were combined and evaporated in-vacuo to yield the title compound as a colourless oil (17 mg, 43%). LCMS (System B) RT=1.62 min, ES+ve m/z 562/564 (M+H)+.

후처리

  1. customThe reaction mixture was partitioned between saturated aqueous sodium hydrogen carbonate solution and ethyl acetate
  2. customThe organic layer was separated
  3. washwashed with brine-water (1:1)
  4. customevaporated in-vacuo
  5. customto yield a colourless oil
  6. stirringThe mixture was stirred at room temperature for 1 hour
  7. stirringstirred for 90 min
  8. stirringstirred for 90 min
  9. customThe reaction mixture was evaporated in-vacuo
  10. customto yield a colourless oil
  11. customDMSO (1 mL) and purified by MDAP Sunfire C18 column
  12. washeluting with solvents A/B (A: 0.1% v/v solution of formic acid in water, B
  13. custom(25 min run)
  14. customevaporated in-vacuo

출처 및 근거

ORD 기록
ord-37608fbbd8034fdba290475aba015388
출처 데이터셋
uspto-grants-2013_08
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US08507543B2

반응 노트

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트